Product Information
TRIFLUOPERAZINE 5 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.8947 per EA under NDC 00781803401. Its NADAC has been published 381 times since Mar 13, 2019.
Strength
5 mg/1
Manufacturer
Sandoz Inc.NDC
00781803401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TRIFLUOPERAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA085789On Market Since
11/20/1981
Pharmacological Classes
Price Statistics
The NADAC for TRIFLUOPERAZINE 5 MG TABLET has been published 381 times since Mar 13, 2019, and over the history we have for it it has declined 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8947 per EA |
|---|---|
| All-time high | $0.9911 (Nov 13, 2019) |
| All-time low | $0.6607 (Dec 21, 2022) |
| 52-week high | $0.8947 |
| 52-week low | $0.7087 |
| Median price | $0.8355 |
| Average price | $0.8319 |
| Largest weekly change | -29.9% (Dec 21, 2022) |
| Weeks tracked | 381 |
| Tracking since | Mar 13, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Trifluoperazine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TRIFLUOPERAZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIFLUOPERAZINE 5 MG TABLET, manufactured by Sandoz Inc., is $0.8947 per EA (NDC 00781803401), effective Jun 24, 2026.
How has the price of TRIFLUOPERAZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIFLUOPERAZINE 5 MG TABLET has declined 6.0%. It has been tracked across 381 weekly CMS publications since Mar 13, 2019.
What are the highest and lowest recorded NADAC prices for TRIFLUOPERAZINE 5 MG TABLET?
Since Mar 13, 2019, the NADAC for TRIFLUOPERAZINE 5 MG TABLET has ranged from a low of $0.6607 (Dec 21, 2022) to a high of $0.9911 (Nov 13, 2019), with a median of $0.8355 per EA.
Are there cheaper alternatives to TRIFLUOPERAZINE 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TRIFLUOPERAZINE 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures TRIFLUOPERAZINE 5 MG TABLET?
TRIFLUOPERAZINE 5 MG TABLET (NDC 00781803401) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification